FA vs JAZZ · P/E 318, rev $860.2M vs P/E 1988, rev $4.07B
First Advantage Corp (FA) versus Jazz Pharmaceuticals PLC (JAZZ) — a side-by-side from cached financials, not a winner call.
First Advantage Corp (FA) is a specialty business services company listed on US.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Latest reported FA revenue for 2024-12-31 was $860.2M. Net income was -$110.3M. Revenue was up 12.6% from 2023-12-31 to 2024-12-31. FA currently screens at market cap $2.72B and trailing P/E 317.6.
Latest reported JAZZ revenue for 2024-12-31 was $4.07B. Net income was $560.1M. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
FA currently screens at market cap $2.72B and trailing P/E 317.6. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Not investment advice. Open the FA and JAZZ stock pages for the full models.
Not investment advice.